Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
34523 | 69 | 34.3 | 89% |
Classes in level above (level 2) |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | ST EUGENIO CTO A ALESINI HOSP | Address | 1 | 100% | 3% | 2 |
2 | CYCLIC GUANYLYL MONOPHOSPHATE | Author keyword | 1 | 50% | 1% | 1 |
3 | CIBER PATHOPHYSIOL OBES NUTR | Address | 0 | 33% | 1% | 1 |
4 | HUMAN VISCERAL ADIPOCYTES | Author keyword | 0 | 33% | 1% | 1 |
5 | NITRIC OXIDE SYNTHASE ISOFORM | Author keyword | 0 | 33% | 1% | 1 |
6 | NOC18 | Author keyword | 0 | 33% | 1% | 1 |
7 | UNIT PL BIOCHEM | Address | 0 | 33% | 1% | 1 |
8 | 3T3L1 CELLS | Author keyword | 0 | 25% | 1% | 1 |
9 | ENDOTHELIAL HEALTH | Author keyword | 0 | 25% | 1% | 1 |
10 | SECT MED PATHOPHYSIOL | Address | 0 | 25% | 1% | 1 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | CYCLIC GUANYLYL MONOPHOSPHATE | 1 | 50% | 1% | 1 | Search CYCLIC+GUANYLYL+MONOPHOSPHATE | Search CYCLIC+GUANYLYL+MONOPHOSPHATE |
2 | HUMAN VISCERAL ADIPOCYTES | 0 | 33% | 1% | 1 | Search HUMAN+VISCERAL+ADIPOCYTES | Search HUMAN+VISCERAL+ADIPOCYTES |
3 | NITRIC OXIDE SYNTHASE ISOFORM | 0 | 33% | 1% | 1 | Search NITRIC+OXIDE+SYNTHASE+ISOFORM | Search NITRIC+OXIDE+SYNTHASE+ISOFORM |
4 | NOC18 | 0 | 33% | 1% | 1 | Search NOC18 | Search NOC18 |
5 | 3T3L1 CELLS | 0 | 25% | 1% | 1 | Search 3T3L1+CELLS | Search 3T3L1+CELLS |
6 | ENDOTHELIAL HEALTH | 0 | 25% | 1% | 1 | Search ENDOTHELIAL+HEALTH | Search ENDOTHELIAL+HEALTH |
7 | TRANSWELLS | 0 | 25% | 1% | 1 | Search TRANSWELLS | Search TRANSWELLS |
8 | WEIGHT REDUCTION SURGERY | 0 | 14% | 1% | 1 | Search WEIGHT+REDUCTION+SURGERY | Search WEIGHT+REDUCTION+SURGERY |
9 | TYPE 5 PHOSPHODIESTERASE | 0 | 13% | 1% | 1 | Search TYPE+5+PHOSPHODIESTERASE | Search TYPE+5+PHOSPHODIESTERASE |
10 | CULTURED CELL DIFFERENTIATION | 0 | 100% | 1% | 1 | Search CULTURED+CELL+DIFFERENTIATION | Search CULTURED+CELL+DIFFERENTIATION |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | C 6 GLIAL CELLS | 1 | 17% | 4% | 3 |
2 | HORMONE STIMULATED LIPOLYSIS | 0 | 25% | 1% | 1 |
3 | ADIPONECTIN SYNTHESIS | 0 | 20% | 1% | 1 |
4 | ENDOTHELIAL FUNCTIONS | 0 | 17% | 1% | 1 |
5 | RECEPTOR BOUND FRACTION | 0 | 17% | 1% | 1 |
6 | SOLUBLE LEPTIN | 0 | 13% | 1% | 1 |
7 | ASTROGLIOGENESIS | 0 | 11% | 1% | 1 |
8 | REGIONAL LIPOLYSIS | 0 | 100% | 1% | 1 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references |
% act. ref. to same field |
---|---|---|---|---|
Nitric oxide production by adipocytes: A role in the pathogenesis of insulin resistance? | 2000 | 18 | 23 | 22% |
Phosphodiesterase type 5 (PDE5) in the adipocyte: a novel player in fat metabolism? | 2011 | 7 | 68 | 9% |
Phosphodiesterase 5 as target for adipose tissue disorders | 2013 | 0 | 52 | 13% |
The role of DNA methylation in etiopathology of coronary heart diseases | 2010 | 0 | 43 | 5% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | ST EUGENIO CTO A ALESINI HOSP | 1 | 100% | 2.9% | 2 |
2 | CIBER PATHOPHYSIOL OBES NUTR | 0 | 33% | 1.4% | 1 |
3 | UNIT PL BIOCHEM | 0 | 33% | 1.4% | 1 |
4 | SECT MED PATHOPHYSIOL | 0 | 25% | 1.4% | 1 |
5 | IND HYG OCCUPAT MED | 0 | 20% | 1.4% | 1 |
6 | MED TRANSFUSIOL | 0 | 20% | 1.4% | 1 |
7 | ENDOCRINE METABOL | 0 | 14% | 1.4% | 1 |
8 | KATEDRA BIOCHEM KLIN | 0 | 11% | 1.4% | 1 |
9 | EDIFICIO CIFA | 0 | 100% | 1.4% | 1 |
10 | INSERM CJF 94 02CHI POISSY | 0 | 100% | 1.4% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000184957 | NUTRITIVE FLOW//NON NUTRITIVE FLOW//INSULIN TRANSPORT |
2 | 0.0000158502 | ADIPOSE TISSUE BLOOD FLOW//AD TAT EXERCISE//AD TAT ORGANISME EXERCICE MUSCULAIRE |
3 | 0.0000125259 | H 411E CELLS//JIANG TANG KE LI JTKL//ADIPOCYTE SECRETED FACTORS |
4 | 0.0000119022 | POLYASPARTOYL L ARGININE//BEIJING S HYDRONE PEPTIDES//CHAIR SEMEIOL MED METHODOL |
5 | 0.0000102245 | VASCULAR ENDOTHELIAL DYSFUNCTION//MOL CARDIOBIOL PROGRAM//VASCULAR ENDOTHELIUM DYSFUNCTION |
6 | 0.0000101495 | ADIPOGENESIS//PREADIPOCYTE//ADIPOCYTE DIFFERENTIATION |
7 | 0.0000097557 | ADIPOSE TISSUE MACROPHAGES//OBES BIOL UNIT//OBESITY INDUCED INFLAMMATION |
8 | 0.0000085671 | DIETARY NITRATE//BEETROOT JUICE//NITRATE SUPPLEMENTATION |
9 | 0.0000072542 | TYPE I INTERLEUKIN 1 RECEPTOR//INOS PROMOTER//ORG SCI TECHNOL |
10 | 0.0000072375 | PERILIPIN//LIPID DROPLET//ADIPOSE TRIGLYCERIDE LIPASE |